Do desipramine [10,11-dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f] azepine monohydrochloride] and fluoxetine [N-methyl-3-phenyl-3-[4- (trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats?

Journal of Pharmacology and Experimental Therapeutics

Volumn 327, Issue 3, 2008, Pages 846-850

  Guemei, Aida Ahmad ^a   El Din, Nagwa Mahmoud Nour ^a   Baraka, Azza Mohamed ^a   Darwish, Inas El Said ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; GLUTATHIONE; INTERLEUKIN 1BETA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; COLITIS; COLON INJURY; COLON ULCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; ENTERITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; COLITIS; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; GLUTATHIONE; INTERLEUKIN-1BETA; MALE; PEROXIDASE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349168117     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.141259     Document Type: Article

References (40)

1. Abdel-Salam OM, Baiuomy AR, and Arbid MS (2004) Studies on the antiinflammatory effect of fluoxetine in the rat. Pharmacol Res 49:119-131.
2. Abdel-Salam OM, Nofal SM, and El-Shenawy SM (2003) Evaluation of the antiinflammatory and anti-nociceptive effects of different antidepressants in the rat. Pharmacol Res 48:157-165.
3. Addolorato G, Capristo E, Stefanini GF, and Gasbarrini G (1997) Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 32:1013-1021.
4. Anisman H and Merali Z (2003) Cytokines, stress and depressive illness: brainimmune interactions. Ann Med 35:2-11.
5. Argaud L, Prigent AF, Chalabreysse L, Loufouat J, Lagarde M, and Ovize M (2004) Ceramide in the antiapoptotic effect of ischemic precondition. Am J Physiol Heart Circ Physiol 286:H246-H251.
6. Beutler B (1995) Immunity and inflammatory disease: lessons of the past decade. J Investig Med 43:227-235.
7. Bradley PP, Priebat DA, Christensen RD, and Rothstein G (1982) Measurements of cutaneous inflammation: estimation of neutrophil content with enzyme marker. J Invest Dermatol 78:206-209.
8. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, and Herkenham M (1991) Long-term antidepressant administration alters corticotrophin-releasing hormone, tyrosine hydroxylase and mineralocorticoid receptor gene expression in rat brain: therapeutic implications. J Clin Invest 87:831-837.
9. Bristow AF, Mosley K, and Poole S (1991) Interleukin-1β production in vivo and in vitro in rats and mice measured using specific immunoradiometric assays. J Mol Endocrinol 7:1-7.
10. Chang JC and Cohen RD (2004) Medical therapy of inflammatory bowel disease: medical management of severe ulcerative colitis. Gastroenterol Clinics North Am 33:235-250.
11. Corda S, Laplace C, Vicaut E, and Duranteau J (2001) Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 24:762-768.
12. Cui J, Engelman RM, Maulik N, and Das DK (2004) Role of ceramide in ischemic myocardium. J Am Coll Surg 198:770-777.
13. Diamond M, Kelly JP, and Connor TJ (2006) Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 16:481-490.
14. Dredge K, Connor TJ, Kelly JP, and Leonard BE (1999) Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1β and tumor necrosis factor-α secretion following an in vivo lipopolysaccharide challenge in rats. Int J Immunopharmacol 21:663-673.
15. Eigler A, Sinha B, Hartmann G, and Endres S (1997) Taming TNF, strategies to restrain this proinflammatory cytokine. Immunol Today 18:487-492.
16. Ghia JE, Blennerhassett P, and Collins SM (2008) Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 118:2209-2218.
17. Gionchetti P, D'Arienzo A, Rizzello F, Manguso F, Maieron R, Lecis PE, Valpiani D, Iaquinto G, Annese V, Balzano A, et al. (2005) Tropical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial. J Clin Gastroenterol 39:291-297.
18. Huether G and Schuff-Werner P (1996) Platelet serotonin acts as a locally releasable antioxidant. Adv Exp Med Biol 398:299-306.
19. Jakobovits SL and Travis SP (2006) Management of acute severe colitis. Br Med Bull 75-76:131-144.
20. Kolla N, Wei Z, Richardson JS, and Li XM (2005) Amitriptyline and fluoxetine protect PC 12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurosci 30:196-201.
21. Kubera M, Kenis G, Bosmans E, Kajta M, Basta-Kaim A, Scharpe S, Budziszewska B, and Maes M (2004) Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 4:185-192.
22. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, and Maes M (2001a) Anti-inflammatory effects of antidepressants through suppression of the interferon-(gamma)/interleukin-10 production ratio. J Clin Psychopharmacol 21:199-206.
23. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, and Shani J (2001b) Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cylokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord 63:171-178.
24. Kubera M, Maes M, Kenis G, Kim YK, and Lasoń W (2005) Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res 134:251-258.
25. Kurina LM, Goldacre MJ, Yeates D, and Gill LE (2001) Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 55:716-720.
26. Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, and Tilg H (2004) Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol 138:323-329.
27. Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25-46.
28. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ, and Blake DR (1996) Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407-415.
29. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, and Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the colon. Gastroenterology 96:795-803.
30. Olden KW (2002) Diagnosis of irritable bowel syndrome. Gastroenterology 122:1701-1714.
31. Owens CW and Bechler RV (1965) A colorimetric micro-method for determination of glutathione. Biochem J 94:705-711.
32. Papadakis KA and Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51:289-298.
33. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429.
34. Slamon ND and Pentreath VW (2000) Antioxidant defense against antidepressant in C6 and 1321 N1 cells. Chem Biol Interact 127:181-199.
35. S?uzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, and Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762:474-476.
36. Song C, Killeen AA, and Leonard BE (1994) Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. Neuropsychobiology 30:24-28.
37. Sood A, Midha V, Sood N, Bhatia AS, and Avasthi G (2003) Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 52:1587-1590.
38. Stallmach A, Schuppan D, Riese HH, Matthes H, and Riecken EO (1992) Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 102:1920-1929.
39. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, et al. (2003) Oxidative stress mediates tumor necrosis factor-alpha-mediated mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:1418-1423.
40. Yang SK, Loftus EV Jr, and Sandborn WJ (2001) Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 7:260-270.